{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:57:47Z","timestamp":1770483467012,"version":"3.49.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1002\/smrj.37","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T07:41:15Z","timestamp":1416987675000},"page":"24-35","source":"Crossref","is-referenced-by-count":15,"title":["Management of Recurrent Ischemic Priapism 2014: A Complex Condition with Devastating Consequences"],"prefix":"10.1093","volume":"3","author":[{"given":"Michael P.","family":"Hoeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1002\/smrj.37_bb0010","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.37_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-5347(17)45549-2","article-title":"The ultrastructure of erectile tissue in priapism","volume":"135","author":"Spycher","year":"1986","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0025","first-page":"9","article-title":"Pharmacologic erection: Time\u2010dependent changes in the corporal environment","volume":"6","author":"Broderick","year":"1994","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.37_bb0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11934-012-0258-9","article-title":"Stuttering priapism: Insights into the pathogenesis and management","volume":"13","author":"Morrison","year":"2012","journal-title":"Curr Urol Rep"},{"key":"10.1002\/smrj.37_bb0035","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","article-title":"Incidence of priapism in the general population","volume":"57","author":"Eland","year":"2001","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0040","unstructured":"Centers for Disease Control and Prevention. Sickle cell disease: Data & statistics 2011. Accessed at: http:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html (accessed September 16, 2014)."},{"key":"10.1002\/smrj.37_bb0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle\u2010cell disease; incidence, risk factors and complications\u2014An international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"10.1002\/smrj.37_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/1757-1626-1-429","article-title":"Sickle cell trait and priapism: A case report and review of the literature","volume":"1","author":"Birnbaum","year":"2008","journal-title":"Cases J"},{"key":"10.1002\/smrj.37_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0094-0143(02)00119-2","article-title":"Urologic manifestations of hematologic disease sickle cell, leukemia, and thromboembolic disease","volume":"30","author":"Molitierno","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1002\/smrj.37_bb0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00043426-199911000-00013","article-title":"Prevalence of priapism in children and adolescents with sickle cell anemia","volume":"21","author":"Mantadakis","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1002\/smrj.37_bb0065","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","article-title":"Priapism and impotence in homozygous sickle cell disease","volume":"140","author":"Emond","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1002\/smrj.37_bb0070","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1743-6109.2008.00770.x","article-title":"Sickle cell disease status and outcomes of African\u2010American men presenting with priapism","volume":"5","author":"Bennett","year":"2008","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.21110","article-title":"Hemoglobin\u2010E beta thalassemia presenting with recurrent priapism\u2014A rare complication","volume":"83","author":"Sharma","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1002\/smrj.37_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1743-6109.2007.00631.x","article-title":"Glucose\u20106\u2010phosphate dehydrogenase deficiency: An etiology for idiopathic priapism?","volume":"5","author":"Burnett","year":"2008","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0085","first-page":"3702","article-title":"Stuttering priapism associated with hereditary spherocytosis","volume":"14","author":"Prabhakaran","year":"2007","journal-title":"Can J Urol"},{"key":"10.1002\/smrj.37_bb0090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ucl.2007.08.006","article-title":"Priapism: Current principles and practice","volume":"34","author":"Burnett","year":"2007","journal-title":"Urol Clin North Am"},{"key":"10.1002\/smrj.37_bb0095","first-page":"46","article-title":"Drug\u2010induced priapism: Its etiology, incidence and treatment","volume":"4","author":"Banos","year":"1989","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"10.1002\/smrj.37_bb0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase\u20105A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/smrj.37_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ucl.2011.02.005","article-title":"Priapism: New concepts in medical and surgical management","volume":"38","author":"Burnett","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1002\/smrj.37_bb0110","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1464-410X.2011.10367.x","article-title":"Treating stuttering priapism","volume":"108","author":"Kheirandish","year":"2011","journal-title":"BJU Int"},{"key":"10.1002\/smrj.37_bb0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1743-6109.2005.00095.x","article-title":"Testosterone and sleep\u2010related erections: An overview","volume":"2","author":"Montorsi","year":"2005","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0120","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1743-6109.2005.00094.x","article-title":"The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function","volume":"2","author":"Granata","year":"2005","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0125","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/j.1939-4640.1997.tb01967.x","article-title":"Relationship between sleep\u2010related erections and testosterone levels in men","volume":"18","author":"Granata","year":"1997","journal-title":"J Androl"},{"key":"10.1002\/smrj.37_bb0130","series-title":"Glenn's Urologic Surgery","first-page":"487","article-title":"Priapism","author":"Bivalacqua","year":"2010"},{"key":"10.1002\/smrj.37_bb0135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2164\/jandrol.110.011890","article-title":"Daily phosphodiesterase type\u20105 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation: A case report","volume":"32","author":"Pierorazio","year":"2011","journal-title":"J Androl"},{"key":"10.1002\/smrj.37_bb0140","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1742-1241.2008.01780.x","article-title":"Stuttering priapism\u2010a review of the therapeutic options","volume":"62","author":"Muneer","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1002\/smrj.37_bb0145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1210\/jcem-57-4-732","article-title":"Site of action of low dose ketoconazole on androgen biosynthesis in men","volume":"57","author":"Santen","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/smrj.37_bb0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jsm.12359","article-title":"Prevention of recurrent ischemic priapism with ketoconazole: Evolution of a treatment protocol and patient outcomes","volume":"11","author":"Hoeh","year":"2014","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0155","series-title":"UpToDate","article-title":"Ketoconazole (systemic): Drug information","year":"2014"},{"key":"10.1002\/smrj.37_bb0160","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.urology.2009.04.071","article-title":"Treatment of recurrent priapism in sickle cell anemia with finasteride: A new approach","volume":"74","author":"Rachid\u2010Filho","year":"2009","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.urology.2007.08.035","article-title":"Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer","volume":"71","author":"Smith","year":"2008","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0170","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.urology.2004.02.005","article-title":"Idiopathic stuttering priapism: Recovery of detumescence mechanism with temporal use of antiandrogen","volume":"63","author":"Yamashita","year":"2004","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0175","first-page":"167","article-title":"Successful treatment of stutter priapism with an antiandrogen","volume":"4","author":"Costabile","year":"1998","journal-title":"Tech Urol"},{"key":"10.1002\/smrj.37_bb0180","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1743-6109.2011.02255.x","article-title":"Persistent sexual side effects of finasteride for male pattern hair loss","volume":"8","author":"Irwig","year":"2011","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-5347(17)35520-9","article-title":"Gonadotropin releasing hormone analogues in the treatment of sickle cell anemia associated priapism","volume":"150","author":"Levine","year":"1993","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1096\/fj.13-228817","article-title":"Sustained nitric oxide (NO)\u2010releasing compound reverses dysregulated NO signal transduction in priapism","volume":"28","author":"Lagoda","year":"2014","journal-title":"FASEB J"},{"key":"10.1002\/smrj.37_bb0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pedn.2011.10.006","article-title":"The use of sudafed for priapism in pediatric patients with sickle cell disease","volume":"27","author":"Mocniak","year":"2012","journal-title":"J Pediatr Nurs"},{"key":"10.1002\/smrj.37_bb0200","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-5347(17)41335-8","article-title":"Treatment of persistent penile erection and priapism using terbutaline","volume":"141","author":"Shantha","year":"1989","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0205","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.ijir.3901180","article-title":"Oral terbutaline in the management of pharmacologically induced prolonged erection","volume":"16","author":"Priyadarshi","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.37_bb0210","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/00005392-199805000-00033","article-title":"A possible mechanism for alteration of human erectile function by digoxin: Inhibition of corpus cavernosum sodium\/potassium adenosine triphosphatase activity","volume":"159","author":"Gupta","year":"1998","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0215","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigational Group","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/smrj.37_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","article-title":"Follow\u2010up of sickle cell disease patients with priapism treated by hydroxyurea","volume":"77","author":"Saad","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1002\/smrj.37_bb0225","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0003-9993(98)90061-2","article-title":"Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions","volume":"79","author":"Denys","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1002\/smrj.37_bb0230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.sc.3101547","article-title":"Management of recurrent priapism in a cervical spinal cord injury patient with oral baclofen therapy","volume":"42","author":"Vaidyanathan","year":"2004","journal-title":"Spinal Cord"},{"key":"10.1002\/smrj.37_bb0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/AAC.30.2.206","article-title":"Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers","volume":"30","author":"Huang","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/smrj.37_bb0240","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.juro.2009.06.040","article-title":"Ketoconazole and prednisone to prevent recurrent ischemic priapism","volume":"182","author":"Abern","year":"2009","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0245","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/JCO.1989.7.8.1093","article-title":"High dose ketoconazole in advanced hormone\u2010refractory prostate cancer: Endocrinologic and clinical effects","volume":"7","author":"Trump","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1002\/smrj.37_bb0250","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0022-5347(05)64675-7","article-title":"Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer","volume":"168","author":"Harris","year":"2002","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0255","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S1677-55382012000500014","article-title":"Finasteride for recurrent priapism in children and adolescents: A report on 5 cases","volume":"38","author":"Barroso","year":"2012","journal-title":"Int Braz J Urol"},{"key":"10.1002\/smrj.37_bb0260","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00005392-199501000-00054","article-title":"Management of recurrent priapism with epinephrine self\u2010injection and gonadotropin\u2010releasing hormone analogue","volume":"153","author":"Steinberg","year":"1995","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0265","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/13543784.10.4.709","article-title":"LHRH analogues as anticancer agents: Pituitary and extrapituitary sites of action","volume":"10","author":"Limonta","year":"2001","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1002\/smrj.37_bb0270","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin\u2010releasing hormone agonists and fracture risk: A claims\u2010based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1002\/smrj.37_bb0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1002\/smrj.37_bb0280","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","author":"Nguyen","year":"2014","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.37_bb0285","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.juro.2006.07.151","article-title":"Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer","volume":"176","author":"Joly","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-4295(01)01492-3","article-title":"Antiandrogens in the treatment of priapism","volume":"59","author":"Dahm","year":"2002","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0295","first-page":"25","article-title":"Idiopathic ischemic priapism: Preventing recurrence","volume":"16","author":"Levine","year":"2004","journal-title":"Contemp Urol"},{"key":"10.1002\/smrj.37_bb0300","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1743-6109.2005.00106.x","article-title":"Idiopathic stuttering priapism treated successfully with low\u2010dose ethinyl estradiol: A single case report","volume":"2","author":"Shamloul","year":"2005","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0305","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajh.10069","article-title":"Short period of administration of diethylstilbestrol in stuttering priapism in sickle cell anemia","volume":"69","author":"Gbadoe","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1002\/smrj.37_bb0310","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","article-title":"Stilboestrol and stuttering priapism in homozygous sickle\u2010cell disease","volume":"2","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/smrj.37_bb0315","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MBC.0b013e32833b2b84","article-title":"Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy","volume":"21","author":"DeSancho","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1002\/smrj.37_bb0320","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"key":"10.1002\/smrj.37_bb0325","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","article-title":"Long\u2010term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism","volume":"67","author":"Burnett","year":"2006","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9343(02)01165-8","article-title":"Sildenafil relieves priapism in patients with sickle cell disease","volume":"113","author":"Bialecki","year":"2002","journal-title":"Am J Med"},{"key":"10.1002\/smrj.37_bb0335","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1111\/j.1743-6109.2009.01285.x","article-title":"Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: A case report","volume":"6","author":"Tzortzis","year":"2009","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0340","doi-asserted-by":"crossref","first-page":"e68028","DOI":"10.1371\/journal.pone.0068028","article-title":"Sildenafil citrate\u2010restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress","volume":"8","author":"Bivalacqua","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1002\/smrj.37_bb0345","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jsm.12391","article-title":"Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis","volume":"11","author":"Musicki","year":"2014","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.37_bb0350","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.urology.2004.12.003","article-title":"Intracavernosal etilefrine self\u2010injection therapy for recurrent priapism: One decade of follow\u2010up","volume":"65","author":"Teloken","year":"2005","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0355","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0090-4295(96)00027-1","article-title":"Preventative treatment of priapism in sickle cell disease with oral and self administered intracavernous injection of etilefrine","volume":"47","author":"Virag","year":"1996","journal-title":"Urology"},{"key":"10.1002\/smrj.37_bb0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000464011","article-title":"Intracorporeal self\u2010injection with epinephrine as treatment for idiopathic recurrent priapism","volume":"17","author":"van Driel","year":"1990","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.37_bb0365","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-5347(05)66371-9","article-title":"Intracavernosal phenylephrine for recurrent priapism: Self administration by drug delivery implant","volume":"165","author":"Ralph","year":"2001","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0370","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-5347(01)66575-3","article-title":"Intracorporeal phenylephrine in the treatment of priapism","volume":"155","author":"Muruve","year":"1996","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0375","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-5347(17)37781-9","article-title":"Treatment of pharmacological priapism with phenylephrine","volume":"146","author":"Dittrich","year":"1991","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0380","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/adc.85.1.52","article-title":"Management of sickle cell priapism with etilefrine","volume":"85","author":"Gbadoe","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1002\/smrj.37_bb0385","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1046\/j.1365-2141.2002.03691.x","article-title":"Etilefrine for the prevention of priapism in adult sickle cell disease","volume":"118","author":"Okpala","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1002\/smrj.37_bb0390","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1464-410X.1997.00285.x","article-title":"Treatment of intermittent idiopathic priapism with oral terbutaline","volume":"80","author":"Ahmed","year":"1997","journal-title":"Br J Urol"},{"key":"10.1002\/smrj.37_bb0395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0090-4295(93)90338-B","article-title":"Placebo\u2010controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1\u2010induced prolonged erections","volume":"42","author":"Lowe","year":"1993","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0400","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/j.1476-5381.1995.tb15054.x","article-title":"Possible role of Na(+)\u2010K(+)\u2010ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide","volume":"116","author":"Gupta","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1002\/smrj.37_bb0405","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/aja.2011.114","article-title":"Medical management of ischemic stuttering priapism: A contemporary review of the literature","volume":"14","author":"Levey","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1002\/smrj.37_bb0410","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11255-014-0737-7","article-title":"Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: A case report and review of the literature","volume":"46","author":"Anele","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1002\/smrj.37_bb0415","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.ijir.3901165","article-title":"Gabapentin in the management of the recurrent, refractory, idiopathic priapism","volume":"16","author":"Perimenis","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.37_bb0420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0361-9230(94)00235-S","article-title":"The GABA\u2010B antagonist CGP 35348 inhibits the effects of baclofen on sexual behavior and motor coordination","volume":"36","author":"Paredes","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1002\/smrj.37_bb0425","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(88)90245-6","article-title":"Inhibition of sexual reflexes by lumbosacral injection of a GABA\u2010B agonist in the male rat","volume":"31","author":"Birtran","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1002\/smrj.37_bb0430","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1097\/BRS.0b013e31818d04ff","article-title":"Favorable response to intrathecal, but not oral, baclofen of priapism in a patient with spinal cord injury","volume":"34","author":"D'Aldeo","year":"2009","journal-title":"Spine"},{"key":"10.1002\/smrj.37_bb0435","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/S0022-5347(05)64201-2","article-title":"Treatment of recurrent idiopathic priapism with oral baclofen","volume":"168","author":"Rourke","year":"2002","journal-title":"J Urol"},{"key":"10.1002\/smrj.37_bb0440","first-page":"590","article-title":"Recurrent priapism in the young patient treated with baclofen","volume":"2","author":"Moreira","year":"2006","journal-title":"J PediatrUrol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115300950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115300950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T09:57:20Z","timestamp":1717581440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052115300950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2050052115300950"],"URL":"https:\/\/doi.org\/10.1002\/smrj.37","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}